Causes, incidence, and risk factors
Hartnup disorder is possibly the most common metabolic condition involving amino acids. It is an inherited condition. A child must inherit a copy of the defective gene from both parents in order to be seriously affected.
The condition usually starts between ages 3 - 5 years.
Most people show no symptoms. If symptoms do occur, they usually appear in childhood and may include:
Signs and tests
A urine test that checks for high levels of "neutral" amino acids and normal levels of other amino acids may be done for this disorder.
The gene for Hartnup has been found, but DNA testing is not yet available. Biochemical tests are available.
- Avoiding sun exposure by wearing protective clothing and using a sunscreen of factor 15 or higher
- Eating a high-protein diet
- Taking supplements containing nicotinamide
- Undergoing psychiatric treatment, such as the use of antidepressants or mood stabilizers, if mood swings or psychiatric problems occur
Most people with this disorder can expect to live a normal life with no disability. Rarely, there have been reports of severe nervous system disease and even deaths in families with this disorder.
There are usually no complications. When they occur, complications may include:
- Changes in skin pigment that are permanent
- Psychiatric problems
- Uncoordinated movements
Nervous system symptoms are usually reversible. However, in rare cases they can be severe or life-threatening.
Calling your health care provider
Call for an appointment with your health care provider if you have symptoms of this condition, especially if you have a family history of Hartnup disorder. Genetic counseling is recommended if you have a family history of this condition and are planning a pregnancy.
Genetic counseling may help prevent some cases. Eating a high-protein diet may prevent amino acid deficiencies that cause symptoms.
Rezvani I. Defects in metabolism of amino acids. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 85.
Reviewed By: Chad Haldeman-Englert, MD, Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.